ADYNOVATE

Product NDC
0944-4627
11-digit product format
009444627
Labeler code
0944
Product ID
0944-4627_23fe329d-5d0a-4ebd-8dae-34a74a23b1d4
Type
PLASMA DERIVATIVE
Nonproprietary name
Antihemophilic Factor (Recombinant) PEGylated
Dosage form
KIT
Labeler
Takeda Pharmaceuticals Amercia, Inc.
Application
BLA125566
Marketing category
BLA
Marketing start
2015-11-13
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
77dc03a4-fbfc-e6a3-fe95-285bbae40d75Product name220250814
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0944-4627-012020-03-05C16284748780-19d75b9d0-f09d-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution For Intravenous Injection Initial U.S. Approval: 2015
0944-4627-012020-03-05C16284748780-19d75b9d0-f09d-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2015
0944-4627-012020-03-05C16284748780-19d75b9d0-f09d-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2015
0944-4627-012020-01-31C16284748780-19d75b9d0-f09d-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution For Intravenous Injection Initial U.S. Approval: 2015
0944-4627-012020-01-31C16284748780-19d75b9d0-f09d-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2015
0944-4627-012020-01-31C16284748780-19d75b9d0-f09d-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use ADYNOVATE ® safely and effectively. See full prescribing information for ADYNOVATE. ADYNOVATE, (Antihemophilic Factor, Recombinant, PEGylated) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2015

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0944-4141-01ADYNOVATE5 mL in 1 VIAL, GLASSINJECTION, POWDER, LYOPHILIZED,5 mL1500 [iU] in 2mL23
0944-4627-01ADYNOVATE1 in 1 CARTONKIT123
0944-4627-02ADYNOVATE1 in 1 KITKIT123
0944-4627-03ADYNOVATE1 in 1 CONTAINERKIT123

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0944-4627-01EA - Each0944-46277e412be4-b43d-4252-b220-ce208009c31e12017-03-06
0944-4627-02EA - Each0944-4627fb9ede62-c7b3-4e5c-b07f-7f9cb753ec1a12018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0944-4627ADYNOVATE (ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED) KIT [TAKEDA PHARMACEUTICALS AMERCIA, INC.]22Current NDC, Legacy NDC, 4 package rows20250331_ef290433-997f-4e98-86d6-42f6a99d6d18.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1741409Adynovate 1 UNT InjectionPSNef290433-997f-4e98-86d6-42f6a99d6d1823
1741407antihemophilic factor (recombinant) pegylated 1 UNT InjectionPSNef290433-997f-4e98-86d6-42f6a99d6d1823
1741409antihemophilic factor (recombinant) pegylated 1 UNT Injection [Adynovate]SBDef290433-997f-4e98-86d6-42f6a99d6d1823
1741407antihemophilic factor (recombinant) pegylated 1 UNT InjectionSCDef290433-997f-4e98-86d6-42f6a99d6d1823
1741409Adynovate 1 UNT InjectionSYef290433-997f-4e98-86d6-42f6a99d6d1823
1741407rurioctocog alfa pegol 1 UNT InjectionSYef290433-997f-4e98-86d6-42f6a99d6d1823

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0944-4141-01009444141015 mL in 1 VIAL, GLASS5 mlHistorical
0944-4627-01009444627011 KIT in 1 CARTON (0944-4627-01) / 1 CONTAINER in 1 KIT (0944-4627-02) / 1 KIT in 1 CONTAINER (0944-4627-03) * 2 mL in 1 VIAL, GLASS (64764-514-02) * 5 mL in 1 VIAL, GLASS (0944-4141-01) 1 kit2015-11-130000-00-00NoNoCurrent
0944-4627-02009444627021 in 1 KITHistorical
0944-4627-03009444627031 in 1 CONTAINERHistorical